All treatments
Treatment
Darolutamide (Nubeqa, BAY1841788) clinical trials
2 indexed studies · 0 currently recruiting
- Active not recruitingPHASE3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
This study is for men with cancer who are already taking darolutamide in another Bayer study and are doing well. It lets them keep taking the same medicine at the same dose, continuing their treatment journey under medical supervision.
For: CancerUnited States · Argentina · Australia - Active not recruiting
A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described
This study looks at how a medicine called darolutamide (Nubeqa) works in real life for men with prostate cancer that hasn't spread and has stopped responding to other treatments. Doctors have already decided these men will receive darolutamide.
For: Prostate CancerUnited States · Argentina · Austria